Schikan Johannes Gerardus Christiaan Petrus sold $7.0M of PHVS
Schikan Johannes Gerardus Christiaan Petrus sold 200,000 shares of Pharvaris N.V. (PHVS) at $35.00 ($7.00M total) on 2026-09-17.
Original reporting
SEC EDGAR · Schikan Johannes Gerardus Christiaan Petrus
Published Sep 21, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PHVS
Bearish
medium confidence
Mentioned
$PHVS
Relevance
6/10
Decision brief
The 30-second read
01
Why it matters
Direct insider sell could signal negative sentiment.
02
Market read
Primary disclosure of a sizable insider sale.
03
What to watch
No immediate catalyst; sale could be routine liquidity need.
Relevance 6/10Novelty 6/10Timing: post-filing 2026-09-21
Background
SEC Form 4 filing discloses insider transaction.
Company-level read
Ticker impact
Context
Director sold 200,000 shares for $7M, reducing his stake to 115,167 shares.
Expected impact
Potential downward pressure over next few days.
Evidence & confidence
Large sale by a director suggests possible concerns about valuation.
Market effects
Sector
May affect biotech sector sentiment as insider sales are monitored.
Regional
Limited to US biotech investors.
Global
Low global impact.
Counterpoint
What could challenge this read
Insider may be diversifying, not necessarily bearish.
Key entities
- DirectorSchikan Johannes Gerardus Christiaan Petrus
Insider selling shares.
